Многоплодная беременность и секс

ВОПРОС: Многоплодная беременность и секс! Что является противопоказанием к интимной близости? Заранее спасибо!

ОТВЕТ: Многоплодная беременность чаще сопровождается осложнениями. Короткая шейка матки, кровотечения, предлежание плаценты, подтекание околоплодных вод будут основными противопоказаниями для интимной жизни.

 

 

 

Короткая шейка матки и половая жизнь

ВОПРОС: На 31 неделе на УЗИ увидели шейку матки 1 2мм (отправили лежать в больницу и прочее, это не по теме). Был строгий запрет на секс, дабы не было преждевременных родов. Так ли это? Спасибо большое. (далее…)

 

Предлежание плаценты и секс

ВОПРОС: Узи 12 недель сказали, что хорион по задней стенке и край полностью перекрывает внутренний зев. Выделений не было ни разу, сейчас 15 недель. (далее…)

 

Низкая плацента и половая жизнь

ВОПРОС: На 16 неделе беременности по УЗИ врач сказал, что плацента расположена низковато и чтобы я была поосторожнее в интимной жизни. Что бы это значило- поосторожнее? (далее…)

 

Воздержание от секса на ранних сроках беременности

ВОПРОС: Была отслойка на 9 неделе беременности 5 мм. Лежала на собой сохранении. Сказали воздержаться от интима месяц. Но все равно страшно 😳 даже спустя месяц заниматься (далее…)

 

Исследования и проекты, в которых Др. Е.П. Березовская принимала участие

Исследования и проекты, в которых Др. Е.П. Березовская принимала участие

• A cluster randomized controlled trial comparing a conservative management and primary laser surgery in stage 1 TTTS (NAFTNet, Canada, France)
• A randomized trial of antenatal treatment of alloimmune thrombocytopenia (Canada, USA)
• Acardiac twins: complications and outcome of prenatal treatment (Canada)
• Amniopatch after iatrogenic preterm premature rupture of membranes (PPROM) (Canada)
• Antenatally diagnosed congenital lung lesions – natural history of disease from fetus to early childhood (Canada)
• Antenatal Management of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) and Neonatal Outcome According to the Category of Risk (Canada)
• BMI effect on outcome in fetoscopic laser ablation of placental anastomoses for twin-to-twin transfusion syndrome (Canada, UK)
• Canadian Paediatric Surgery Network (CAPSNet): establishing best perinatal practices for gastroschisis and congenital diaphragmatic hernia (Canada)
• Cardiovascular outcome of the recipient twin in severe twin-to-twin pregnancies treated by serial amniocenteses (Canada)
• Cervical cerclage for short cervix during laser surgery for twin twin transfusion syndrome: A multi-center retrospective study (Canada, USA)
• Congenital head and neck masses that were managed by EXIT procedure: outcome review (Canada)
• Congenital diaphragmatic hernia: from prenatal diagnosis to long-term outcomes (Canada)
• Congenital heart disease in multiple pregnancies: diagnosis, spectrum of disease and outcome (Canada)
• Congenital megalourether: prenatal diagnosis and outcome (Canada)
• Cord occlusion in monochorionic twin pregnancies (Canada, Belgium)
• Establishing best perinatal practices for gastroschisis (Canada)
• Etiology of the hemodynamic and placental changes observed in Twin-to-Twin Transfusion Syndrome – from the clinical manifestations to the cellular mechanisms (Canada)
• Evaluation of alpha-thalassemia in pregnancy and impact of fetal therapy on outcome (Canada)
• Evaluation of the performance of a non-invasive test for fetal RHD genotype of the Sequenom Massarray System (Canada, USA)
• Evolution and resolution of cardiac structural and haemodynamic changes in fetuses following selective laser ablation of placental anastomoses for stage 4 TTTS (Canada)
• Fetal atrial flutter & supraventricular tachycardia (FAST) therapy trial (Canada, USA, Europe)
• Fetal bladder extrophy: case series and review of literature (Canada)
• Fetal CDH: our experience, management and conclusion (Canada)
• Fetal CNS abnormalities: evaluation of US and MRI findings for prognosis and outcome (Canada)
• Fetal pleuroamniotic shunting for macrocystic lung lesions (Canada)
• Fetoscopic laser surgery for Twin-to-Twin Transfusion Syndrome before 17 and after 26 weeks gestation (Canada, USA)
• Impact of fetal blood group genotyping on management of hemolytic disease of the newborn (Canada)
• Inflammatory mediated damage to fetal bowel in gastroschisis: multi-centre prospective study (Canada)
• Inter-observer and intra-observer discrepancy in measurements of the lung head ratio (Canada)
• International trial of antioxidants for the prevention of preeclampsia (INTAPP) (Canada, Mexico, China)
• Intravenous immunoglobulin for the treatment of severe maternal red cell alloimmunisation (Canada)
• Investigating the impact of antenatal steroids on gastroschisis gut function (Canada, UK)
• Massive fetal abdominal distension: the role for antepartum drainage (Canada)
• MATernal Hyperoxygenation in Congenital Heart Disease (MATCH) (Canada, USA)
• Maternal and fetal outcomes following cephalocentesis (Canada)
• Maternal hemodynamic and hematologic changes following treatment by laser of TTTS (Canada)
• Mechanism of in utero demise of fetuses with congenital heart disease (Canada)
• MCA Doppler in a surviving co-twin relationship to subsequent brain MRI findings and clinic outcome (Canada)
• Middle cerebral artery doppler to determine the timing o second and subsequent fetal blood transfusions for women with alloimmunization (Canada, Australia)
• Minimally invasive management of Rh alloimmunized pregnancies: can amniotic fluid OD 450 measurements be replaced by Doppler ultrasound studies (DIAMOND Study) (Canada, The Netherlands)
• Minimally invasive fetal therapy for bronchopulmonary sequestrations with hydrops: 3 different approaches and review of the literature (Canada)
• Neonatal outcome after EXIT procedure (Canada)
• Neurodevelopmental outcomes of survivors of co-twin death (Canada)
• North American Fetal Therapy Network: complicated monochorionic twin pregnancy registry (Canada, USA)
• Ontario Fetal Alert Network (Canada)
• Observed to Expected Lung to Head Ratio and Liver Herniation in the Prediction of DH Outcome in a Contemporaneous Multi-Center Cohort (Canada, USA)
• Outcomes of different anesthetic techniques in fetoscopic selective laser ablation of placental anastomoses for Twin-Twin Transfusion Syndrome (TTTS) (Canada, Belgium, Australia)
• Outcome of pregnancy with rare cases of abdominal wall defects (Canada)
• Outcomes of prenatally diagnosed hemoglobin Bart’s disease with or without fetal therapy (Canada)
• Oxidative stress in fetuses with decompensated alloimmune haemolitic disease of the fetus and newborn (NAFTNet) (Canada, USA)
• Parvovirus infection in pregnancy: management, outcome and our experience (Canada)
• Prediction of outcome of fetal congenital diaphragmatic hernia by lung to liver signal intensity ration by fetal MRI (Canada)
• Prediction of outcome for infants with abdominal wall defects (Canada)
• PPROM: outpatient vs. inpatient management (Canada)
• Pregnancy and Neonatal Outcomes in Large Choriangiomas (Canada)
• Pregnancy and newborn outcome after intrauterine pleural shunt insertion in fetuses affected with pleural effusion (Canada)
• Pregnancy outcome in complicated monochorionic twins undergoing selective reduction (Canada, USA)
• Quality assessment of the maternal fetal medicine intrauterine transfusion program (Canada)
• Randomized clinical trial: expectant management vs. laser ablation of communicating vessels in monochorionic twins with selective intrauterine growth restriction (Canada, USA)
• Randomized trial of fetoscopic endoluminal tracheal occlusion (FETO) (Canada, Spain, France, UK)
• Retrospective assessment of outcomes in monoamniotic twin pregnancies (Canada)
• Review of fetal and neonatal haemangioma and lymphangiomas (Canada)
• Short and long term outcomes of LUTO (Canada)
• The accuracy of sonographic fetal weight estimation (Canada)
• The neurodevelopmental outcome and impact on the family for twin pregnancies who underwent laser ablation therapy or amnioreduction for Twin-to-Twin Transfusion Syndrome (Canada)
• The role of cephalocentesis in the management of the severely hydrocephalic fetus (Canada)
• The value of serial titres in Kell alloimmunized pregnancies (Canada)
• TTTS outcome and complications after Laser Ablation (Canada)
• TTTS pregancies after laser therapy: prediction of fetal/neonetal death (NAFTNet) (Canada, USA)
• Twin Anemia-Polycythemia Sequence: Perinatal management and Outcome — The Toronto Experience (Canada)
• Twin-Twin Transfusion Syndrome Stage III-IY quasi-randomized trials (Canada, USA)
• Vascular limb occlusion in Twin-Twin Transfusion Syndrome (Canada)
• Chronic Disease of GIT in Reproductive Age Women: Influence of Hormonal Contraceptives on the Process of Recovery (Ukraine)
• Folic Acid and Congenital Anomalies of Teeth (Ukraine)
• Treatment of PID in the Light of Woman’s Menstrual Cycle (Ukraine)
• Breastfeeding in a Process of Adaptation of Children Born with Different Stages of Hypoxia (Ukraine)
• Medical Properties of Plants of the Carpathians (Ukraine)
• Effect of Pollution on fermentative Activity of Soil (Ukraine)

 

Побочные эффекты от приема КОК «Джес»

ВОПРОС: Врач прописал мне препарат «Джес» для восстановления цикла. На второй месяц приема у меня начала очень сильно болеть грудь в области подмышек, вздулись и стали (далее…)

 

Зуд и выделения на фоне приема ОК. Стоит ли менять препарат?

ВОПРОС: 10 месяцев принимаю препарат «Димиа». В последние 2 месяца, за неделю до месячных, появляется зуд и желтые выделения без запаха. Консультировалась со своим гинекологом, (далее…)

 
Сертификаты Елены Петровны

Сертификаты Елены Петровны

Елена Петровна имеет более 200 сертификатов в:

— гинекологической онкологии      — женской сексологии

— доказательной медицине           — репродуктивной медицине

— альтернативной медицине         — нутрициологии

В альбоме представлена только часть сертификатов.

(далее…)

 

Зуд голеностопного сустава как побочный эффект от КОК?

ВОПРОС: Врач прописал оральные контрацептивы «Джес плюс», по причине заниженного прогестерона. На 5-ый день приема начало чесаться в районе голеностопного сустава правой ноги, (далее…)